Question 1

What are the potential side effects of LY2157299 and lomustine?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Dose-Escalation Study in Participants With Recurrent Malignant Glioma clinical trial (NCT01682187). Contact the study team or your healthcare provider for specific answers.

Question 2

How does this trial compare to other treatment options I have?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Dose-Escalation Study in Participants With Recurrent Malignant Glioma clinical trial (NCT01682187). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the requirements for participating in this study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Dose-Escalation Study in Participants With Recurrent Malignant Glioma clinical trial (NCT01682187). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to come in for visits during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Dose-Escalation Study in Participants With Recurrent Malignant Glioma clinical trial (NCT01682187). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects during the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Dose-Escalation Study in Participants With Recurrent Malignant Glioma clinical trial (NCT01682187). Contact the study team or your healthcare provider for specific answers.

Question 6

Will I need to stop any current medications before starting this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Dose-Escalation Study in Participants With Recurrent Malignant Glioma clinical trial (NCT01682187). Contact the study team or your healthcare provider for specific answers.

What this study is about